4
Changes in Ownership
ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-24-003231
Chief Medical Officer gave up 755 shares (to pay taxes)
- Chief Medical Officer acquired 2,576 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rottinghaus Scott T. Chief Medical Officer | 2024-02-12 | Grant or award | +2,576 | 29,042 | D | ||
| Rottinghaus Scott T. Chief Medical Officer | 2024-02-12 | Shares withheld for taxes | −755 | $12.41 | $9,370 | 28,287 | D |
Loading xslF345X05/form4.xml…